Universal Health Services (UHS) Bank of America Global Healthcare Conference 2026 summary

Financial performance and revenue drivers

• Revenues increased by about 8%, with same-store behavioral revenue up 7%, driven by pricing and Medicaid supplemental payments.

• Seasonal factors, such as a weaker flu season and weather disruptions, impacted volumes, with underlying volume growth around 2%.

• Medicaid supplemental payments contributed a $133 million year-over-year increase, while exchange-related headwinds and new hospital openings created a $20 million negative impact.

• Exchange volume declines are expected to steepen through the year, with a $75 million impact anticipated.

• Florida Medicaid supplemental program approval for 2025 will provide a $100 million incremental benefit; 2026 approval is pending but expected to be similar.

Operational strategy and growth initiatives

• Volume growth is projected at 2%-3% for the year, supported by new capacity in acute care and ongoing investments in behavioral headcount.

• Headcount growth in behavioral is moderating to align more closely with volume, targeting around 2% for 2026.

• New hospital openings, including a 30th facility in Florida and de novo projects, are expected to drive embedded growth.

• Outpatient strategy is emphasized, with investments in clinics and the Talkspace acquisition to expand virtual and step-down care.

• Las Vegas market volumes improved in Q1, with positive outlook due to economic diversification and health plan performance.

Cost management and technology adoption

• Productivity improvements and cost control remain a focus, especially in acute care, with ongoing efforts to optimize length of stay and throughput.

• Revenue cycle management enhancements in acute care are being extended to behavioral, expected to provide a tailwind in 2027.

• AI initiatives are underway, with projects in revenue cycle automation, post-discharge follow-up, and claims management.

• Early investment in Hippocratic AI supports automation and efficiency, with gradual margin benefits anticipated.